AI isn’t close to curing cancer. This startup says it knows what it will take.
A biotech startup called Vivodyne says the AI drug-discovery industry has a data problem,…
Enveda secures $311M to bring more nature-derived AI drugs into clinical trials
The idea behind Enveda is that powerful medicines could be harnessed from plants and…
Startup Battlefield 200 applications close today: Nominate a founder or submit your startup
Today is the final day to apply or nominate a startup for Startup Battlefield 200.…
One week left to book your exhibit table at TechCrunch Disrupt 2026
Lead-generation tools through the Disrupt app so you can capture prospects and follow up…
3 days left to exhibit: Turn visibility into your next opportunity at TechCrunch Disrupt 2026
This is it: 3 days to get your startup in front of 10,000+ founders,…
Early Bird pricing ends tonight for TechCrunch Founder Summit
Tonight is your last chance to save up to $190 on your pass to TechCrunch…
2 days left to exhibit at TechCrunch Disrupt 2026
Book your exhibit table at TechCrunch Disrupt 2026 by tomorrow, Friday, September 18 at…
The Enhanced Games — tech’s steroid extravaganza — didn’t pay off, as company posts $60 million loss
The event ended up being more than a little anticlimactic. Hailed by its creators…
Anthropic says its biology lab has already found something big
Amodei himself has said one of the things he fears most is that AI…
